MA25562A1 - Procede pour administrer un inhibiteur de phosphodiesterase 4. - Google Patents

Procede pour administrer un inhibiteur de phosphodiesterase 4.

Info

Publication number: MA25562A1
Authority: MA; Morocco
Prior art keywords: phosphodiesterase; administering; inhibitor
Prior art date: 1999-10-29

Application number

MA26618A

Other languages

English (en)

Inventor

J Torphy Theodore

D Zussman Barry

D Murdoch Robert

Original Assignee

Smithkline Beecham Corp

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-29

Filing date

2002-04-26

Publication date

2002-10-01

2002-04-26 Application filed by Smithkline Beecham Corp, Smithkline Beecham Plc filed Critical Smithkline Beecham Corp

2002-10-01 Publication of MA25562A1 publication Critical patent/MA25562A1/fr

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Biomedical Technology (AREA)
Inorganic Chemistry (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Enzymes And Modification Thereof (AREA)

MA26618A 1999-10-29 2002-04-26 Procede pour administrer un inhibiteur de phosphodiesterase 4. MA25562A1 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date
US16247799P	1999-10-29	1999-10-29
US16264199P	1999-11-01	1999-11-01
US17981700P	2000-02-02	2000-02-02

Publications (1)

Publication Number	Publication Date
MA25562A1 true MA25562A1 (fr)	2002-10-01

Family

ID=27388757

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA26618A MA25562A1 (fr)	1999-10-29	2002-04-26	Procede pour administrer un inhibiteur de phosphodiesterase 4.

Country Status (29)

Country	Link
US (1)	US20030212112A1 (fr)
EP (1)	EP1225884A4 (fr)
JP (1)	JP2003513038A (fr)
KR (1)	KR20020050249A (fr)
CN (1)	CN1387433A (fr)
AP (1)	AP2002002446A0 (fr)
AR (1)	AR026254A1 (fr)
AU (1)	AU772909B2 (fr)
BG (1)	BG106623A (fr)
BR (1)	BR0015039A (fr)
CA (1)	CA2389293A1 (fr)
CO (1)	CO5271676A1 (fr)
CZ (1)	CZ20021443A3 (fr)
DZ (1)	DZ3249A1 (fr)
EA (1)	EA200200502A1 (fr)
HK (1)	HK1049105A1 (fr)
HU (1)	HUP0203682A3 (fr)
IL (1)	IL148813A0 (fr)
MA (1)	MA25562A1 (fr)
MX (1)	MXPA02004220A (fr)
NO (1)	NO20021937L (fr)
NZ (1)	NZ518002A (fr)
OA (1)	OA12078A (fr)
PE (1)	PE20011004A1 (fr)
PL (1)	PL355262A1 (fr)
SK (1)	SK7292002A3 (fr)
TR (1)	TR200201150T2 (fr)
UY (1)	UY26422A1 (fr)
WO (1)	WO2001032165A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR029984A1 (es) *	2000-07-27	2003-07-23	Smithkline Beecham Corp	Metodo para reducir las exacerbaciones asociadas copd ambito
MY140561A (en)	2002-02-20	2009-12-31	Nycomed Gmbh	Dosage form containing pde 4 inhibitor as active ingredient
DE10207160A1 (de) *	2002-02-20	2003-12-18	Altana Pharma Ag	Darreichungsform enthaltend PDE 4-Hemmer als Wirkstoff
ES2319517T3 (es) *	2002-05-28	2009-05-08	Nycomed Gmbh	Preparacion farmaceutica aplicable topicamente.
US6822114B1 (en)	2002-10-08	2004-11-23	Albemarle Corporation	Process for production of fluoroalkoxy-substituted benzamides and their intermediates
PL1606261T3 (pl)	2003-03-10	2010-04-30	Astrazeneca Ab	Nowy sposób przygotowania roflumilastu
CA2520779A1 (fr) *	2003-03-31	2004-11-11	Kyowa Hakko Kogyo Co., Ltd.	Agent administre par voie orale
US20050026883A1 (en) *	2003-07-31	2005-02-03	Robinson Cynthia B.	Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
EP1861074B1 (fr)	2005-03-16	2013-04-24	Takeda GmbH	Forme de dosage cachant le goût comprenant du roflumilaste
MX2012006265A (es) *	2009-12-03	2012-07-25	Opko Health Inc	Formulaciones disacaridas hipersulfatadas.
WO2013101810A1 (fr) *	2011-12-27	2013-07-04	Celgene Corporation	Formulations de (+)-2-[1-(3-éthoxy-4-méthoxy-phényl)-2-méthanesulfonyl-éthyl]-4-acétylaminoisoindoline-1,3-dione
CN103536582A (zh) *	2013-10-12	2014-01-29	云南龙海天然植物药业有限公司	罗氟司特干粉吸入剂
US20210031012A1 (en)	2018-01-26	2021-02-04	Progenity, Inc.	Treatment of a disease of the gastrointestinal tract with a pde4 inhibitor
CN113348011B (zh)	2018-11-19	2023-04-18	比奥拉治疗股份有限公司	用生物治疗剂治疗疾病的方法和装置
WO2021119482A1 (fr)	2019-12-13	2021-06-17	Progenity, Inc.	Dispositif ingérable pour administrer un agent thérapeutique dans le tractus gastro-intestinal

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4684516A (en) *	1983-08-01	1987-08-04	Alra Laboratories, Inc.	Sustained release tablets and method of making same
AR028986A1 (es) *	1999-02-23	2003-06-04	Smithkline Beecham Corp	USO DE UN INHIBIDOR DE PDE4 EN LA FABRICACIoN DE UNA PREPARACIoN DE LIBERACIoN CONTROLADA; FORMULACION DE LIBERACION CONTROLADA PARA EL TRATAMIENTO DE COPD, UN PROCEDIMIENTO PARA SU PREPARACIoN Y COMPOSICIoN FARMACÉUTICA
AR035987A1 (es) *	1999-03-01	2004-08-04	Smithkline Beecham Corp	Uso de un compuesto inhibidor de la pde 4 para la manufactura de un medicamento y el medicamento para tratar asma inducida por ejercicio

2000
- 2000-10-26 IL IL14881300A patent/IL148813A0/xx unknown
- 2000-10-26 HU HU0203682A patent/HUP0203682A3/hu unknown
- 2000-10-26 KR KR1020027005448A patent/KR20020050249A/ko not_active Application Discontinuation
- 2000-10-26 EP EP00975385A patent/EP1225884A4/fr not_active Withdrawn
- 2000-10-26 BR BR0015039-8A patent/BR0015039A/pt not_active IP Right Cessation
- 2000-10-26 AP APAP/P/2002/002446A patent/AP2002002446A0/en unknown
- 2000-10-26 TR TR2002/01150T patent/TR200201150T2/xx unknown
- 2000-10-26 CO CO00081570A patent/CO5271676A1/es not_active Application Discontinuation
- 2000-10-26 CA CA002389293A patent/CA2389293A1/fr not_active Abandoned
- 2000-10-26 AU AU13445/01A patent/AU772909B2/en not_active Ceased
- 2000-10-26 JP JP2001534370A patent/JP2003513038A/ja not_active Withdrawn
- 2000-10-26 CN CN00815150A patent/CN1387433A/zh active Pending
- 2000-10-26 OA OA1200200126A patent/OA12078A/en unknown
- 2000-10-26 AR ARP000105644A patent/AR026254A1/es not_active Application Discontinuation
- 2000-10-26 DZ DZ003249A patent/DZ3249A1/fr active
- 2000-10-26 EA EA200200502A patent/EA200200502A1/ru unknown
- 2000-10-26 SK SK729-2002A patent/SK7292002A3/sk unknown
- 2000-10-26 MX MXPA02004220A patent/MXPA02004220A/es unknown
- 2000-10-26 CZ CZ20021443A patent/CZ20021443A3/cs unknown
- 2000-10-26 WO PCT/US2000/029453 patent/WO2001032165A1/fr not_active Application Discontinuation
- 2000-10-26 PL PL00355262A patent/PL355262A1/xx unknown
- 2000-10-26 NZ NZ518002A patent/NZ518002A/en unknown
- 2000-10-27 PE PE2000001157A patent/PE20011004A1/es not_active Application Discontinuation
- 2000-10-30 UY UY26422A patent/UY26422A1/es not_active Application Discontinuation
2002
- 2002-04-17 BG BG106623A patent/BG106623A/bg unknown
- 2002-04-24 NO NO20021937A patent/NO20021937L/no not_active Application Discontinuation
- 2002-04-26 MA MA26618A patent/MA25562A1/fr unknown
- 2002-12-19 HK HK02109231.8A patent/HK1049105A1/zh unknown
2003
- 2003-05-02 US US10/429,666 patent/US20030212112A1/en not_active Abandoned

Also Published As

Publication number	Publication date
PE20011004A1 (es)	2001-09-28
CN1387433A (zh)	2002-12-25
BR0015039A (pt)	2002-06-25
TR200201150T2 (tr)	2002-09-23
JP2003513038A (ja)	2003-04-08
WO2001032165A1 (fr)	2001-05-10
EP1225884A1 (fr)	2002-07-31
AU1344501A (en)	2001-05-14
NZ518002A (en)	2004-01-30
CA2389293A1 (fr)	2001-05-10
BG106623A (bg)	2003-02-28
OA12078A (en)	2003-05-28
AR026254A1 (es)	2003-02-05
IL148813A0 (en)	2002-09-12
CO5271676A1 (es)	2003-04-30
HUP0203682A3 (en)	2003-10-28
NO20021937L (no)	2002-05-30
AP2002002446A0 (en)	2002-03-31
CZ20021443A3 (cs)	2003-01-15
US20030212112A1 (en)	2003-11-13
MXPA02004220A (es)	2002-10-17
NO20021937D0 (no)	2002-04-24
EA200200502A1 (ru)	2002-10-31
HUP0203682A2 (hu)	2003-04-28
KR20020050249A (ko)	2002-06-26
DZ3249A1 (fr)	2001-05-10
AU772909B2 (en)	2004-05-13
UY26422A1 (es)	2001-07-31
SK7292002A3 (en)	2002-12-03
PL355262A1 (en)	2004-04-05
HK1049105A1 (zh)	2003-05-02
EP1225884A4 (fr)	2005-06-15

Publication	Publication Date	Title
ZA200108735B (en)	2003-01-23	Renin inhibitors.
ZA200006577B (en)	2002-04-24	Phthalazine derivatives as phosphodiesterase 4 inhibitors.
ZA977694B (en)	1998-02-23	Heterocyclic metalloprotease inhibitors.
MA26250A1 (fr)	2004-08-01	PROCEDE DE CONTRôLE D'UN DETECTEUR.
ITMI20001773A0 (it)	2000-07-31	Dispositivo di lubrificazione per un giunto a lamelle.
ID28489A (id)	2001-05-31	Metode untuk membuat 4-karboksiamino-2-disubstitusi 1,2,3,4-tetrahidroquinolin
MA25562A1 (fr)	2002-10-01	Procede pour administrer un inhibiteur de phosphodiesterase 4.
ZA200001333B (en)	2001-12-18	Method for communicating information.
ZA985416B (en)	1999-12-22	Apo B-secretion/MTP inhibitor hydrochloride salt.
HUP0000536A2 (en)	2002-08-28	Method for levelling a track
ZA995444B (en)	2000-07-10	A method for the treatment of staphylococcal disease.
IT236376Y1 (it)	2000-08-08	Dispositivo di scarico per un crogiolo.
EP1237112A4 (fr)	2006-05-17	Procede de realisation de transactions securisees sur livret bancaire electronique (tirelire)
ZA200110053B (en)	2002-07-03	Factor via inhibitors.
ZA200108980B (en)	2002-10-30	Cold distillation method. Cold distillation method.
IT1317270B1 (it)	2003-05-27	Apparecchiatura a cambio di velocita' per un trattore.
FR2795009B3 (fr)	2001-05-11	Procede pour raccorder des sections de raccordement
IT1316262B1 (it)	2003-04-03	Procedimento per il funzionamento di un autoveicolo.
ITUD990152A0 (it)	1999-08-26	Cingolo per gruppo di traino di macchine trafilatrici
IT1308785B1 (it)	2002-01-10	Gruppo di trasmissione per un veicolo.
FR2833389B1 (fr)	2004-12-03	Systeme et procede visant a empecher le detournement d'avions.
PL346842A1 (en)	2002-02-25	New pharmaceutical uses for nos inhibitors
ITBO980076A0 (it)	1998-02-13	Metodo per il trasferimento di articoli.
FR2794560B1 (fr)	2001-09-21	Procede d'aide a la lecture notamment pour malvoyant
FR2788704B1 (fr)	2002-06-28	Procede de presulfuration d'un catalyseur d'hydrogenation